Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Global Cancer Immunotherapy Market Size study, By Type (Monoclonal Antibodies, Cancer Vaccines, Checkpoint Inhibitors, Immunomodulators), By Application (Lung Cancer, Breast Cancer, Head and Neck Cancer, Prostate Cancer, Colorectal Cancer, Melanoma, Others), By End User (Hospitals, Clinics & Others), and Regional Forecasts 2022-2028
... Clinics & Others), and Regional Forecasts 2022-2028 Global Cancer Immunotherapy Market is valued approximately USD 119.31 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 14.0% over the ... Read More
-
South and Central America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The South and Central America pharmacogenomics market is expected to reach US$ 591.35 million by 2028 from US$ ... Read More
-
Europe Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Europe pharmacogenomics market is expected to reach US$ 3,874.31 million by 2028 from US$ 1,962.48 million in 2021. It is ... Read More
-
North America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The North America pharmacogenomics market is expected to reach US$ 6,534.83 million by 2028 from US$ 3,333.43 million in 2021. ... Read More
-
2022 Cancer Diagnostic Instrumentation, and Strategic Profiles of Leading Suppliers
... assessments of current and emerging suppliers of tumor marker diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Please note: The delivery time for ... Read More
-
2022-2026 Emerging Hematology Tests, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers
... report also presents strategic assessments of current and emerging suppliers of hematology and flow cytometry products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Please ... Read More
-
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 158,442 diagnosed prevalent cases of pancreatic cancer across 16 pharmaceutical markets. There are five leading marketed drugs for the treatment of pancreatic cancer, AstraZeneca is a key player ... Read More
-
Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Cancer Type (Breast Cancer, Lung Cancer, Liver Cancer, Hematological Cancer, Brain Cancer, Prostate Cancer, Pancreatic Cancer, and Others), Route of Administration (Intravenous, Intramuscular, Oral, and Others), Drug Class (HER2 Inhibitor, Immune Checkpoint Inhibitor, PARP Inhibitor, Kinase Inhibitor, and Others), Product (Branded and Generic & Biosimilar), and End User (Hospital, Specialty Clinic, and Others)
... (Intravenous, Intramuscular, Oral, and Others), Drug Class (HER2 Inhibitor, Immune Checkpoint Inhibitor, PARP Inhibitor, Kinase Inhibitor, and Others), Product (Branded and Generic & Biosimilar), and End User (Hospital, Specialty Clinic, and Others) The metastatic cancer ... Read More
-
Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size By Technology (Loop-mediated Isothermal Amplification (LAMP), Strand Displacement Amplification (SDA), Nucleic Acid Sequence-based Amplification (NASBA), Helicase-dependent Amplification (HDA)), By Product (Instruments, Reagents), By Application, (Infectious Disease {HIV, Influenza, Malaria, Tuberculosis}, Oncology, Blood Screening), By End-use (Hospitals, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028
... Influenza, Malaria, Tuberculosis}, Oncology, Blood Screening), By End-use (Hospitals, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook, Growth Potential, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028 The isothermal nucleic acid amplification technology ... Read More
-
Asia Pacific Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Asia Pacific pharmacogenomics market is expected to reach US$ 2,679.64 million by 2028 from US$ 1,148.36 million in 2021. ... Read More
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... Lung Cancer therapeutics. Synopsis In 2022, there will be more than 210,000 diagnosed prevalent cases of SCLC across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of SCLC, AstraZeneca is a ... Read More
-
Global Cancer Supportive Care Drugs Market 2022-2028
... management of physical and psychological symptoms and side-effects across the continuum of the cancer experience from diagnosis through anticancer treatment to post-treatment care. The market for cancer supportive care drugs worldwide is expected to reach ... Read More
-
2022 Global Breast Cancer Liquid Biopsy Industry (2028 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include ... Read More
-
Asia Cervical Cancer Test (Screening) Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19
... cancer caused due to the rampant proliferation of the cell. In 2021, as per our Report Statistics, more than 100 Million populations were diagnosed with cervical cancer. In women, cervical cancer ranks as the 4th ... Read More
-
2022 Global Cancer Biomarkers Industry (2028 Outlook)
... reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include the total value of ... Read More
-
Asia-Pacific Oncology Market Databank
... segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated ... Read More
-
Latin America, Middle East & Africa Oncology Market Databank
... 2021 to 2029. Cancer treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. ... Read More
-
North America Oncology Market Databank
... treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is ... Read More
-
Global Oncology Market Databank
... segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated ... Read More
-
Leading Oncology Cancer Type Markets Databank
... Breast cancer segment is expected to be the highest contributor to this market, with $60,659.5 Million in 2020, and is anticipated to reach $88,239.8 Million by 2029, registering a CAGR of 4.30%. Colon & rectal ... Read More
-
Central America (Costa Rica, Panama, Guatemala, Dominican Republic) Acute Myeloid Leukemia Drugs Market
... 5.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. ... Read More
-
Breast Cancer Screening Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company Analysis
... the most common types of cancer and a significant cause of mortality among women. Thus, early detection is required for breast cancer diseases. Breast cancer is more general in industrialized countries due to its modern ... Read More
-
Europe Oncology Market Databank
... segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is anticipated ... Read More
-
Leading Oncology Country Markets Databank
... is expected to be the highest contributor to this market, with $94,840.8 Million in 2020, and is anticipated to reach $162,447.5 Million by 2029, registering a CAGR of 6.20%. Asia-Pacific and Europe collectively expected to ... Read More
-
Global Head and Neck Cancer Therapeutics Market, By Type (Diagnostic Methods {Biopsy, Imaging, Endoscopy, Others} v/s Treatment Type {Surgery, Radiation Therapy, Chemotherapy, Immunotherapy, Targeted Therapy}), By Treatment Type (By Disease Indication {Lip and Oral Cavity Cancer, Laryngeal Cancer, Oropharyngeal Cancer, Salivary Gland Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer}, By Route of Administration {Injectable, Oral}, By Therapeutic Class {PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors}), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region, Company, Opportunities and Forecast, 2027
... Cancer, Laryngeal Cancer, Oropharyngeal Cancer, Salivary Gland Cancer, Nasopharyngeal Cancer, Hypopharyngeal Cancer}, By Route of Administration {Injectable, Oral}, By Therapeutic Class {PD Inhibitors, EGFR Inhibitors, Microtubule Inhibitors}), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical ... Read More
Research Assistance
